Literature DB >> 15725586

Characterization of MTM1 mutations in 31 Japanese families with myotubular myopathy, including a patient carrying 240 kb deletion in Xq28 without male hypogenitalism.

Tzung-Chang Tsai1, Hideo Horinouchi, Satoru Noguchi, Narihiro Minami, Kumiko Murayama, Yukiko K Hayashi, Ikuya Nonaka, Ichizo Nishino.   

Abstract

X-linked myotubular myopathy is a congenital muscle disorder due to MTM1 mutation, and is characterized clinically by generalized muscle weakness and hypotonia at birth usually resulting in early death. We newly identified 26 unrelated Japanese patients with MTM1 mutations by genomic DNA and transcript analysis, including 12 novel mutations. Among 31 patients, including our previously reported five patients, the c.1261-10A>G splice site mutation was the most frequent mutation. Three mutations, one missense and two splice site, were associated with milder phenotype. Of particular interest, one boy had a 240 kb deletion in Xq28 encompassing CXorf6 (formerly F18), MTM1 and MTMR1 but was not accompanied by hypogenitalism. CXorf6, which have been implicated in male sexual development, was not entirely deleted in this boy, resulting in the fusion with the MTMR1 gene. A chimeric fusion transcript was detected in patient's muscle by RT-PCR, suggesting this fusion gene product avoids the phenotype. This deletion led us to refine the critical region of CXorf6 for the development of male genitalia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15725586     DOI: 10.1016/j.nmd.2004.12.005

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  17 in total

1.  Clinical utility gene card for: Centronuclear and myotubular myopathies.

Authors:  Valérie Biancalana; Alan H Beggs; Soma Das; Heinz Jungbluth; Wolfram Kress; Ichizo Nishino; Kathryn North; Norma B Romero; Jocelyn Laporte
Journal:  Eur J Hum Genet       Date:  2012-05-23       Impact factor: 4.246

2.  Reducing dynamin 2 expression rescues X-linked centronuclear myopathy.

Authors:  Belinda S Cowling; Thierry Chevremont; Ivana Prokic; Christine Kretz; Arnaud Ferry; Catherine Coirault; Olga Koutsopoulos; Vincent Laugel; Norma B Romero; Jocelyn Laporte
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

Review 3.  Congenital myopathies: an update.

Authors:  Jessica R Nance; James J Dowling; Elizabeth M Gibbs; Carsten G Bönnemann
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

4.  Large duplication in MTM1 associated with myotubular myopathy.

Authors:  K Amburgey; M W Lawlor; D Del Gaudio; Y W Cheng; C Fitzpatrick; A Minor; X Li; D Aughton; S Das; A H Beggs; J J Dowling
Journal:  Neuromuscul Disord       Date:  2012-12-28       Impact factor: 4.296

5.  Single Intramuscular Injection of AAV-shRNA Reduces DNM2 and Prevents Myotubular Myopathy in Mice.

Authors:  Hichem Tasfaout; Valentina M Lionello; Christine Kretz; Pascale Koebel; Nadia Messaddeq; Deborah Bitz; Jocelyn Laporte; Belinda S Cowling
Journal:  Mol Ther       Date:  2018-02-14       Impact factor: 11.454

6.  Myotubular myopathy caused by multiple abnormal splicing variants in the MTM1 RNA in a patient with a mild phenotype.

Authors:  Nasim Vasli; Vincent Laugel; Johann Böhm; Béatrice Lannes; Valérie Biancalana; Jocelyn Laporte
Journal:  Eur J Hum Genet       Date:  2012-01-18       Impact factor: 4.246

7.  Expanding the MTM1 mutational spectrum: novel variants including the first multi-exonic duplication and development of a locus-specific database.

Authors:  Jorge Oliveira; Márcia E Oliveira; Wolfram Kress; Ricardo Taipa; Manuel Melo Pires; Pascale Hilbert; Peter Baxter; Manuela Santos; Henk Buermans; Johan T den Dunnen; Rosário Santos
Journal:  Eur J Hum Genet       Date:  2012-09-12       Impact factor: 4.246

Review 8.  Centronuclear (myotubular) myopathy.

Authors:  Heinz Jungbluth; Carina Wallgren-Pettersson; Jocelyn Laporte
Journal:  Orphanet J Rare Dis       Date:  2008-09-25       Impact factor: 4.123

Review 9.  MAMLD1 (CXorf6) is a New Gene for Hypospadias.

Authors:  Tsutomu Ogata; Maki Fukami; Yuka Wada
Journal:  Clin Pediatr Endocrinol       Date:  2008-11-08

10.  Phosphatase-dead myotubularin ameliorates X-linked centronuclear myopathy phenotypes in mice.

Authors:  Leonela Amoasii; Dimitri L Bertazzi; Hélène Tronchère; Karim Hnia; Gaëtan Chicanne; Bruno Rinaldi; Belinda S Cowling; Arnaud Ferry; Bruno Klaholz; Bernard Payrastre; Jocelyn Laporte; Sylvie Friant
Journal:  PLoS Genet       Date:  2012-10-11       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.